Evidence map›Paper›PMID 36004330›Full record

ArticleFrontiers in cellular and infection microbiology2022

Molecular and clinical characterization of hypervirulent

Jun Li, Mengli Tang, Zhaojun Liu, Fengjun Xia, Changhang Min, Yongmei Hu, Haichen Wang, Mingxiang Zou

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Prevalence, Risk Factors, and Clinical Outcomes of HypervirulentIndian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Hybrid Sequencing-Based Genomic Analysis ofInfection and drug resistance · 2024
    Article
  10. The Klebsiella pneumoniaeInfection and immunity · 2023
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jun LiDepartment of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, China.
Mengli TangDepartment of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, China.
Zhaojun LiuDepartment of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, China.
Fengjun XiaDepartment of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, China.
Changhang MinDepartment of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, China.
Yongmei HuDepartment of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, China.
Haichen WangDepartment of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, China.
Mingxiang ZouDepartment of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, China.
Central South University · CNXiangya Hospital Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite being a significant public health concern, hypervirulent

Indexed as

Klebsiella InfectionsUrinary Tract InfectionsAnti-Bacterial AgentsCarbapenemsHumansKlebsiella pneumoniaeVirulenceAnti-Bacterial AgentsCarbapenemsantibiotic resistanceclinical characterizationhypervirulent K. pneumoniaeurinary tract infectionswhole-genome sequencing

Identifiers

PMID36004330
PMCPMC9393326
OpenAlexW4290546639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.